STOCK TITAN

Quest Diagnostics Multi-Pronged Approach to Waste Reduction

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Quest Diagnostics (DGX) aims to implement a waste-to-energy strategy, reduce medical waste, and improve water stewardship by 2025. The company has already made significant progress in waste reduction, plastic waste reduction, paper waste reduction, and water use efficiency.
Positive
  • None.
Negative
  • None.

NORTHAMPTON, MA / ACCESSWIRE / December 13, 2023 / Quest Diagnostics
Originally published in Quest Diagnostics Corporate Responsibility Report 2022

2025/2026 Goals

  • Implement a waste-to-energy strategy to divert from landfills' waste from several of our laboratory locations by 2025
  • Reduce or eliminate shipped medical waste from at least 4 of our laboratory locations by installing on-site treatment technology by 2025

Waste reduction

We have a multi-pronged approach to waste reduction. Our strategies include reducing waste generated and waste sent to landfill.

  • For several years, we have been committed to reducing our single-use plastic waste and using specimen cups and stool containers containing less plastic. We are proud to share this program reduced our plastic waste in 2022 by another 105 standard tons
  • We are committed to reducing the amount of paper waste in our PSCs. During the period 2018-2022, we cut paper waste in our PSCs by approximately 723 tons, including approximately 177 tons in 2022. As we go forward, we estimate that this initiative will enable us to avoid paper waste by approximately 175 tons annually
  • Our plans also include decreasing waste to landfill. We began with an audit of several of our California sites to gain a better understanding of disposal of waste streams. We identified waste-to-energy as a potential opportunity to divert waste from landfills and are planning to implement waste-to-energy projects at not less than 4 laboratory locations by 2025
  • Another waste stream opportunity is medical waste. We plan to install on-site treatment technology for medical waste at 4 laboratories within the next 3 years

Water stewardship

We rely on water for our operations and test processing and are focused on continuously improving water use efficiency and management of water discharges.

  • Our environmental management system includes consideration of water use and its impact on the environment as a limited natural resource
  • We conducted water audits at several of our major laboratories to gather insight into potential water-savings opportunities

Small changes can have a big impact

Annually, Quest ships over 1.5 million collection supplies orders to over 100,000 clients - totaling over 2.5 million boxes. These collection supplies are needed to properly collect a quality sample for testing in our laboratories. In 2022, we began a box optimization program to bring down the number of boxes we send out. Our innovative software solution, launching in 2023, will trim the number of boxes shipped by an estimated 10% annually. This program is expected to reduce downstream cardboard used by 85 tons. There will also be a reduction in transportation carbon emissions as fewer trips will be needed to deliver the same quantity of supplies.

Read more

View additional multimedia and more ESG storytelling from Quest Diagnostics on 3blmedia.com.

Contact Info:
Spokesperson: Quest Diagnostics
Website: https://www.3blmedia.com/profiles/quest-diagnostics
Email: info@3blmedia.com

SOURCE: Quest Diagnostics



View the original press release on accesswire.com

FAQ

What are Quest Diagnostics' (DGX) environmental goals for 2025?

Quest Diagnostics aims to implement a waste-to-energy strategy, reduce or eliminate shipped medical waste, and improve water stewardship by 2025.

How has Quest Diagnostics (DGX) reduced plastic waste?

Quest Diagnostics has reduced plastic waste by implementing a program that reduced plastic waste in 2022 by 105 standard tons, and using specimen cups and stool containers containing less plastic.

What is Quest Diagnostics' (DGX) strategy for reducing paper waste?

Quest Diagnostics has cut paper waste in their Patient Service Centers by approximately 723 tons during the period 2018-2022, and plans to avoid paper waste by approximately 175 tons annually going forward.

What is Quest Diagnostics' (DGX) plan for waste reduction?

Quest Diagnostics plans to implement waste-to-energy projects at not less than 4 laboratory locations by 2025, and install on-site treatment technology for medical waste at 4 laboratories within the next 3 years.

How is Quest Diagnostics (DGX) improving water stewardship?

Quest Diagnostics is focused on continuously improving water use efficiency and management of water discharges, and has conducted water audits at several major laboratories to gather insight into potential water-savings opportunities.

What is Quest Diagnostics' (DGX) box optimization program?

Quest Diagnostics has initiated a box optimization program to reduce the number of boxes shipped by an estimated 10% annually, which is expected to reduce downstream cardboard used by 85 tons and transportation carbon emissions.

Quest Diagnostics Inc.

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Stock Data

15.15B
109.71M
0.43%
91.73%
2.29%
Medical Laboratories
Health Care and Social Assistance
Link
United States of America
SECAUCUS

About DGX

quest diagnostics (nyse: dgx) empowers people to take action to improve health outcomes. derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. quest annually serves one in three adult americans and half the physicians and hospitals in the united states, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. the company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (ap) services, & interpretive consultation through its medical & scientific staff of about 900 m.d.s & ph.d.s. the company reported 2014 revenues of $7.4 billion. quest diagnostics offers the most extensive clinical testing network in the u.s., with laborator